5321 | responsible conduct of research | | 29/12/2022 17:46:50 | |
5322 | GCP | | 29/12/2022 22:15:48 | |
5323 | Citi Program | | 30/12/2022 23:29:07 | |
5324 | CITI program | | 31/12/2022 00:31:20 | |
5325 | GCP 2022 | | 31/12/2022 12:14:21 | |
5326 | Good Clinical Practice & Human Subject Protection Training Program 2022 | | 01/01/2023 12:17:15 | |
5327 | GCP (U.S. FDA Focus) for IRB members, Researchers, Faculty members | | 02/01/2023 22:41:24 | |
5328 | GCP Clinical Trials Involving Investigational Devices for IRB members, Researchers, Faculty members | | 02/01/2023 22:42:08 | |
5329 | Good clinical practice and human subject protection training for certificate | | 02/01/2023 22:53:23 | |
5330 | GCP training | | 03/01/2023 08:45:24 | |
5331 | Importance of GCP | | 03/01/2023 09:52:25 | |
5332 | Standard Course in Clinical Trials and GCP training Program 2021 | | 03/01/2023 14:15:55 | |
5333 | Good Clinical Practice & Human Subject Protection Training Program 2022 | | 03/01/2023 14:23:06 | |
5334 | Certificate of Attendance in “Good Clinical Practice & Human Subject Protection Training Program 2022” from Faculty of Medicine, Chulalongkorn University | | 03/01/2023 14:45:09 | |
5335 | CITI program | | 08/09/2023 14:45:06 | |
5336 | Good Clinical Practice (U.S. FDA Focus) | | 03/01/2023 15:36:28 | |
5337 | Responsible Conduct of Research | | 03/01/2023 15:37:10 | |
5338 | Good Clinical Practice Course for Clinical Trails Involving Drugs (ICH focus) | | 03/01/2023 15:37:38 | |
5339 | CITI Confliects of Interest | | 03/01/2023 15:38:14 | |
5340 | Good Clinical Practice Course for Clinical Trials Involving Devices (international focus) | | 03/01/2023 15:38:50 | |